|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 14.04 EUR | -4.23% |
|
+2.93% | +166.67% |
| 03/07 | Genfit soars on news of U.S. reimbursement for a product |  |
| 03/07 | Genfit's Liver Disease Blood Test Approved for US Medicare Reimbursement | MT |
| Market Cap | 70Cr 81Cr 66Cr 60Cr 113.5Cr 7.7TCr 115.48Cr 773.17Cr 302.81Cr 3.84TCr 303.55Cr 296.82Cr 13TCr | P/E 2026 * |
36.2x | P/E 2027 * | 93.2x |
|---|---|---|---|---|---|
| Enterprise Value | 65Cr 75Cr 61Cr 56Cr 105.24Cr 7.14TCr 107.08Cr 716.9Cr 280.77Cr 3.56TCr 281.45Cr 275.22Cr 12TCr | EV / Sales 2026 * |
6.5x | EV / Sales 2027 * | 5.13x |
| Free-Float |
86.88% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | -4.23% | ||
| 1 week | +2.93% | ||
| Current month | -4.23% | ||
| 1 month | +8.50% | ||
| 3 months | +73.76% | ||
| 6 months | +118.18% | ||
| Current year | +166.67% |
| 1 week | 12.98 |  | 15.48 |
| 1 month | 12.32 | | 15.48 |
| Current year | 5.05 | | 15.48 |
| 1 year | 3.05 | | 15.48 |
| 3 years | 2.62 | | 15.48 |
| 5 years | 2.62 | | 15.48 |
| 10 years | 2.62 | | 35.65 |
| Manager | Title | Age | Since |
|---|---|---|---|
Pascal Prigent
CEO | Chief Executive Officer | 58 | 16/09/2019 |
Thomas Baetz
DFI | Director of Finance/CFO | 52 | 22/04/2021 |
Pejvack Motlagh
CTO | Chief Tech/Sci/R&D Officer | - | 27/11/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 70 | 16/06/2017 | |
| Director/Board Member | 54 | 15/09/1999 | |
| Director/Board Member | 58 | 16/06/2017 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 12/07/23 | Buy | Director | 5,300 | 0.0106% | ||
| 07/07/23 | Buy | Chief Executive Officer | 10,000 | 0.0201% | ||
| 07/07/23 | Buy | Founder | 10,000 | 0.0201% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -4.23% | +2.93% | +316.86% | +324.81% | 84Cr | |
| -0.36% | +0.14% | -2.06% | +14.33% | 4.85TCr | |
| -2.71% | -2.99% | +398.09% | +472.12% | 3.99TCr | |
| -0.71% | +9.45% | +27.90% | +7.89% | 3.87TCr | |
| -0.71% | -3.72% | +4.94% | +52.45% | 3.51TCr | |
| -2.41% | +1.96% | +11.68% | +38.17% | 2.98TCr | |
| -0.66% | -2.73% | +35.50% | +122.17% | 1.61TCr | |
| -0.19% | -3.93% | - | - | 1.61TCr | |
| -0.62% | +1.23% | +2.76% | +15.05% | 1.36TCr | |
| -3.15% | -6.14% | -4.82% | -36.90% | 1.26TCr | |
| Average | -1.58% | +0.29% | +87.87% | +112.23% | 2.51TCr | |
| Weighted average by Cap. | -1.25% | +1.16% | +77.33% | +105.38% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 10Cr 12Cr 9.35Cr 8.59Cr 16Cr 1.1TCr 16Cr 110.3Cr 43Cr 547.99Cr 43Cr 42Cr 1.81TCr | 12Cr 14Cr 12Cr 11Cr 20Cr 1.36TCr 20Cr 136.56Cr 53Cr 678.43Cr 54Cr 52Cr 2.24TCr |
| Net income | 2.29Cr 2.63Cr 2.14Cr 1.96Cr 3.7Cr 250.91Cr 3.76Cr 25Cr 9.86Cr 125.12Cr 9.89Cr 9.67Cr 412.7Cr | 68L 78.24L 63.49L 58.28L 1.1Cr 75Cr 1.12Cr 7.49Cr 2.93Cr 37Cr 2.94Cr 2.87Cr 122.67Cr |
| Net Debt | -5.11Cr -5.88Cr -4.77Cr -4.38Cr -8.26Cr -560.61Cr -8.4Cr -56Cr -22Cr -279.57Cr -22Cr -22Cr -922.12Cr | -6.62Cr -7.61Cr -6.18Cr -5.67Cr -11Cr -725.73Cr -11Cr -73Cr -29Cr -361.91Cr -29Cr -28Cr -1.19TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 03/26/03 | €14.04 | -4.23% | 6,14,321 |
| 31/26/31 | €14.66 | +4.71% | 10,52,589 |
| 30/26/30 | €14.00 | +3.09% | 4,72,097 |
| 29/26/29 | €13.58 | +2.88% | 2,21,321 |
| 28/26/28 | €13.20 | -3.23% | 3,09,495 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GNFT Stock
Select your edition
All financial news and data tailored to specific country editions
